No Data
Earnings Preview: SCPH to Report Financial Results Post-market on November 13
$scPharmaceuticals(SCPH.US)$ is scheduled to release its financial results post-market on November 13 ET. Earnings PreviewAnalysts estimate $scPharmaceuticals(SCPH.US)$ to post revenue of USD10.80M
ScPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Leerink Partners Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $20
Strategic Growth and Market Expansion Opportunities Drive Buy Rating for ScPharmaceuticals
Maxim Group Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $20
Strategic Buy Rating for ScPharmaceuticals: Furoscix's Potential in CKD Market
No Data
No Data